#radioligand therapy Tech News.
1 story in the last 7 days
The latest radioligand therapy news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks radioligand therapy across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
HealthFinancial Postabout 4 hours ago
Curium wins patent case, clears path for GEP-NET therapyCurium prevailed in a patent dispute brought by Novartis subsidiary Advanced Accelerator Applications over Curium's Lutetium Lu 177 dotatate product. The Delaware U.S. District Court ruled all relevant patent claims invalid and not infringed. The decision allows Curium to launch its therapy for GEP-NETs in the U.S.
Summaries by ByteBrief